My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

AnaptysBio, Inc. - Common Stock (NQ:ANAB)

44.88 +1.08 (+2.47%)

Streaming Delayed Price Updated: 2:42 PM EST, Dec 10, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AnaptysBio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

GSK Unveils Detailed Phase 3 Data For Jemperli In Frontline Endometrial Cancer Patients ↗

March 28, 2023

Via Benzinga

AnaptysBio- and GSK-partnered immuno-oncology agent Jemperli (dostarlimab-gxly) plus chemotherapy demonstrates statistically significant and clinically meaningful improvement in progression-free survival for the treatment of primary advanced or recurrent

March 27, 2023

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

March 01, 2023

From AnaptysBio, Inc.

Via GlobeNewswire

HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround ↗

September 19, 2022

Via Benzinga

AnaptysBio Sells Royalty Interest In Cancer Drug For $45M ↗

September 12, 2022

Via Benzinga

Raymond James Initiates AnaptysBio With ~42% Upside, Despite Trial Setback ↗

September 02, 2022

Via Benzinga

AnaptysBio to Participate at the Cowen and Company 43rd Annual Health Care Conference

February 27, 2023

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio Announces Stock Repurchase Plan

January 13, 2023

From AnaptysBio, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 06, 2023

Via Benzinga

Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday ↗

January 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 05, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗

January 06, 2023

Via Benzinga

AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies

January 05, 2023

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio- and GSK-partnered immuno-oncology agent JEMPERLI (dostarlimab-gxly) meets primary endpoint in Phase 3 RUBY trial in primary advanced or recurrent endometrial cancer

December 02, 2022

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio to Participate at the Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

From AnaptysBio, Inc.

Via GlobeNewswire

Expert Ratings for AnaptysBio ↗

November 09, 2022

Over the past 3 months, 4 analysts have published their opinion on AnaptysBio (NASDAQ:ANAB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

AnaptysBio to Participate in Upcoming November Investor Conferences

November 09, 2022

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update

November 08, 2022

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial ↗

October 05, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022 ↗

November 01, 2022

Upgrades

Via Benzinga

AnaptysBio and GSK-partnered immuno-oncology agents JEMPERLI (dostarlimab-gxly) and cobolimab show positive progress in two separate non-small cell lung cancer trials

October 05, 2022

From AnaptysBio, Inc.

Via GlobeNewswire

This Analyst Slashes PT On Rent the Runway By Around 43%, Plus JP Morgan Predicts $84 For Oracle ↗

September 13, 2022

Credit Suisse cut the price target for Rent the Runway, Inc. (NASDAQ: RENT) from $7 to $4. Rent the Runway shares fell 30.6% to trade at $3.42 on Tuesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022 ↗

September 13, 2022

Upgrades See all analyst ratings upgrades.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022 ↗

September 01, 2022

Upgrades

Via Benzinga

AnaptysBio Faces Another Setback For Imsidolimab, Stalls Work In Skin Scarring Indication ↗

September 01, 2022

AnaptysBio Inc (NASDAQ: ANAB) announced topline data from its HARP Phase 2 trial of imsidolimab for moderate-to-severe hidradenitis suppurativa (HS).

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

September 01, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 31, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 07, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.